Search This Blog

Friday, August 16, 2019

Plus Therapeutics reports Q2 results

Plus Therapeutics (NASDAQ:PSTV): Q2 GAAP EPS of -$5.12.
Revenue of $0.3M (-66.7% Y/Y)
Press Release
10Q
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)